Clinical trial
Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination…
NCT00400777 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00400777 |
|---|---|
| Title | Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension |
| Official title | An Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy of the Combination of Valsartan and Hydrochlorothiazide and Amlodipine in Hypertensive Patients Not Controlled With Valsartan and Hydrochlorothiazide |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Valsartan, hydrochlorothiazide and amlodipine |
| Enrollment | 460 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | Nov 17, 2006 |
| Last update posted | Jun 18, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: